Quantinno Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Quantinno Capital Management's CTKB Position: Q3 2026 in Review
Quantinno Capital Management increased its Cytek Biosciences (CTKB) stake by 43% in Q3 2026, buying an estimated $116K and bringing the position to 81,295 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #3172.
Quantinno Capital Management first reported a position in CTKB in Q4 2024 and has held it in 6 quarters since. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- Quantinno Capital Management held 81,295 shares of Cytek Biosciences worth $485K as of Q3 2026.
- Quantinno Capital Management bought 24,472 Cytek Biosciences shares in Q3 2026, an estimated $116K.
- Cytek Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3172 holding.
- Quantinno Capital Management first reported a position in Cytek Biosciences in Q4 2024 and has held it in 6 quarters since.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.